Author

Pauline Koopmans

Institutions: University Medical Center Groningen, University of Groningen

Observed institutions: University Medical Center Groningen, University of Groningen

OpenAlex ID: A5111534353

Pharmacokinetics of Vincristine Monotherapy in Childhood Acute Lymphoblastic Leukemia

2002 · Ellis Groninger, Tiny Meeuwsen-de Boer, et al. · Pediatric Research · 74

Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing

2002 · Stewart J. Kellie, Draga Barbaric, et al. · Cancer · 66

Increasing the dosage of vincristine

2004 · Stewart J. Kellie, Pauline Koopmans, et al. · Cancer · 41

Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG)

2004 · Ellis Groninger, Tiny Meeuwsen-de Boer, et al. · European Journal of Cancer · 39

Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process

2019 · Bahez Gareb, Silke Posthumus, et al. · Pharmaceutics · 21

An Automated HPLC Method to Determine Intracellular Vincristine Concentrations in Mononuclear Cells of Children with Acute Lymphoblastic Leukemia

2003 · Ellis Groninger, Pauline Koopmans, et al. · Therapeutic Drug Monitoring · 13

Baclofen Stability up to One Year in In Vivo Intrathecal Infusion Pumps

2023 · Tommi K. Korhonen, Pauline Koopmans, et al. · Neuromodulation Technology at the Neural Interface · 2

Pitfalls of “long‐distance pharmacokinetics.” Shipment of biologic samples to reference laboratories

2002 · Stewart J. Kellie, Donald R.A. Uges, et al. · Medical and Pediatric Oncology · 2

Roadmap for the accelerated development and clinical translation of fluorescent tracers: Adalimumab-680LT as a proof of concept

2026 · Henrik K. Huizinga, Rosalie J. van Dijken, et al. · International Journal of Pharmaceutics X · 1

Tangential flow filtration as a novel approach for fluorescent tracer purification and production up-scaling: cetuximab-800CW and ustekinumab-800CW as a proof-of-concept

2026 · Henrik K. Huizinga, Rosalie J. van Dijken, et al. · mAbs

Works count: 10

Citation count: 259

H-index: 6

I10-index: 6